Preview

Safety and Risk of Pharmacotherapy

Advanced search

The journal "Safety and Risk of Pharmacotherapy" is an information partner of the IV Congress NOLI NOCERE!

On May 19–22, 2026, the IV Russian Congress "Safety of Pharmacotherapy 360°: NOLI NOCERE!" will take place a key event for specialists in the field of drug safety and clinical practice. The event will be attended by leading experts in pharmacovigilance and clinical pharmacology, as well as physicians of various specialties: gastroenterologists, cardiologists, psychiatrists, oncologists, and others.

The Congress has been held since 2022 under the leadership of Academician of the Russian Academy of Sciences, Doctor of Medical Sciences, Professor Dmitry Alekseevich Sychev – Chief External Expert - Clinical Pharmacologist of the Ministry of Health of Russia, Head of the World-Class Genomic Research Center "Center for Predictive Genetics, Pharmacogenetics and Personalized Therapy" of the Russian Scientific Center of Surgery named after academician B.V. Petrovsky, President of the Eurasian Association of Clinical Pharmacology and Pharmacovigilance, Honored Scientist of the Russian Federation, and a member of the Editorial Board of the journal "Safety and Risk of Pharmacotherapy".

The journal "Safety and Risk of Pharmacotherapy" traditionally acts as an information partner of the Congress, and its editorial policy is inextricably linked with the goals and objectives of this event. It is particularly significant that within the framework of the Congress, a competition of scientific works by young scientists in the field of drug safety – "LekBez" – is held. The best works will be recommended by the competition jury for publication in the journal "Safety and Risk of Pharmacotherapy".